Company: NGVT
Filing Date: 2025-03-10
Form Type: PREC14A
Source: 0001308179-25-000061
Chunk: 17

Company: Ingevity Corp
Filing Date: 2025-03-10
Form: PREC14A
Chunk 17
---
                                                                                                                            
 enable the nominee to meaningfully participate in deliberations of the Board and committees and to otherwise fulfill his or her duties;          
 and                                                                                                                                              |
| n | whether the nominee will                                                                                                                         
 enhance the diversity of the Board based on his or her personal educational and professional background, experience, viewpoints or perspectives. |

In addition, the Nominating & Governance Committee considers character, financial literacy, and relevant skills in light of the Board’s needs. The Nominating & Governance Committee considers recommendations for director candidates from Board members, stockholders, and other third parties, such as search firms, that are regularly engaged to assist with identifying candidates. The Nominating & Governance Committee evaluates candidates recommended by stockholders using the same criteria it uses for all other candidates. Any stockholder wishing to recommend a director candidate should provide the Nominating & Governance Committee with the information required by the Company’s Bylaws to be provided with respect to director nominees submitted by stockholders. For more information, see “Questions and Answers Regarding Stockholder Communications, Stockholder Proposals, and Company Documents.” Board Refreshment and Succession Planning The Board believes that periodic refreshment of its directors is vital to ensuring that the Board remains current and reflects a diversity of skills, professional experience and backgrounds. In order to encourage refreshment, the Board recently adopted a mandatory director retirement age of 72 and a mandatory term limit on its Board chair of no more than two successive two-year terms, in each case, unless the Board determines that it is in the best interests of the Company’s stockholders to make an exception. Since 2022, the Board has added three new independent directors. In December 2024, the Board appointed a new independent director, J. Kevin Willis, who was vetted by a third-party search firm, the Nominating & Governance Committee and the Board. The Nominating and Governance Committee actively engages in succession planning for the Board at least annually and more frequently as the situation warrants. The Nominating and Governance Committee reviews the skills and experience of the Board to identify opportunities to recruit directors that enhance areas of focus. In selecting Mr. Willis, the Nominating & Governance Committee and the Board focused on adding additional financial expertise from a sitting chief financial officer with particular expertise in capital management and driving business transformation in the specialty chemicals sector. Director independence Our Guidelines and the NYSE require that a majority of our directors be independent under the applicable rules and regulations of the SEC and the general listing standards of the NYSE. Our Board